Elicio Therapeutics Analyst Ratings
Elicio Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 76.47% | HC Wainwright & Co. | → $12 | Assumes | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 10 月 26 日 | 76.47% | HC Wainwright & Co. | → 12 美元 | 假設 | → 購買 |
What is the target price for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的目標價格是多少？
The latest price target for Elicio Therapeutics (NASDAQ: ELTX) was reported by HC Wainwright & Co. on October 26, 2023. The analyst firm set a price target for $12.00 expecting ELTX to rise to within 12 months (a possible 76.47% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年10月26日公佈了Elicio Therapeutics（納斯達克股票代碼：ELTX）的最新目標股價。該分析公司將目標股價定爲12.00美元，預計ELTX將在12個月內上漲（可能上漲76.47％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的最新分析師評級是多少？
The latest analyst rating for Elicio Therapeutics (NASDAQ: ELTX) was provided by HC Wainwright & Co., and Elicio Therapeutics their buy rating.
Elicio Therapeutics（納斯達克股票代碼：ELTX）的最新分析師評級由HC Wainwright & Co. 提供，Elicio Therapeutics的買入評級。
When is the next analyst rating going to be posted or updated for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elicio Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elicio Therapeutics was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Elicio Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Elicio Therapeutics的最後一次評級是在2023年10月26日發佈的，因此您應該預計下一個評級將在2024年10月26日左右公佈。
Is the Analyst Rating Elicio Therapeutics (ELTX) correct?
分析師評級Elicio Therapeutics（ELTX）是否正確？
While ratings are subjective and will change, the latest Elicio Therapeutics (ELTX) rating was a with a price target of $0.00 to $12.00. The current price Elicio Therapeutics (ELTX) is trading at is $6.80, which is within the analyst's predicted range.
儘管評級是主觀的，而且將發生變化，但最新的Elicio Therapeutics（ELTX）評級爲A，目標股價爲0.00美元至12.00美元。Elicio Therapeutics（ELTX）目前的交易價格爲6.80美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。